Tailor-made enzyme solutions for production processes of biologics

7

Context/Overview
Biologics, including mRNA-based therapeutics/vaccines and antibody drug conjugates (ADCs), have demonstrated groundbreaking benefits in healthcare, offering not only preventive measures against viral infections but also targeted therapies with reduced side effects for cancer and autoimmune diseases. Nevertheless, the manufacturing of such Biologics is a sophisticated process with still several challenges to address.